Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering

Area of Science:

• Immunology
• Molecular Biology
• Microbiology

Background:

• Toll-like receptor (TLR) overactivation contributes to severe inflammatory conditions and organ damage.
• Tight regulation of TLR responses is crucial for controlling disease progression.

Purpose of the Study:

• To investigate the regulatory role of soluble Toll-like receptor 2 (sTLR2) in inflammatory responses.
• To elucidate the mechanisms by which sTLR2 modulates TLR2-mediated inflammation.

Main Methods:

• Overexpression of sTLR2 in cells and administration of sTLR2 protein to mice.
• Assessment of cellular responses (NF-kappaB activation, phagocytosis, superoxide production) to TLR2 ligands.
• Analysis of immune cell infiltration and bacterial clearance in vivo.

Main Results:

• Cells and mice treated with sTLR2 exhibited hyporesponsiveness to TLR2 ligands, with reduced NF-kappaB activation and inflammatory cell recruitment.
• sTLR2 acted as a decoy receptor, interfering with TLR2 signaling complex formation and CD14 interaction.
• sTLR2 modulated acute inflammation without compromising the ability to clear Gram-positive bacterial infections.

Conclusions:

• sTLR2 is a key regulator of TLR2-mediated inflammation, dampening excessive immune responses.
• sTLR2 functions by preventing TLR2 signaling complex assembly and acting as a decoy.
• sTLR2 represents a promising therapeutic target for managing acute and chronic inflammatory diseases.